Compare ICICI Prudential Healthcare Fund vs UTI Healthcare Fund
ICICI Prudential Healthcare Fund
EquitySectoral-Pharma
UTI Healthcare Fund
EquitySectoral-Pharma
Risk
Very High
Very High
Rating
4.0
4.0
Min SIP Amount
₹100
₹500
Expense Ratio
2.07
2.23
NAV
₹43.47
₹354.64
Fund Started
25 Jun 2018
01 Aug 2005
Fund Size
₹6861.20 Cr
₹1429.84 Cr
Exit Load
Exit load of 1% if redeemed within 15 days.
Exit load of 1% if redeemed within 30 days.
1 Year
-1.65%
5.98%
3 Year
19.02%
19.93%
5 Year
14.15%
13.58%
Equity
98.91%
94.12%
Cash
1.09%
5.85%
Top 10 Holdings
Name | Assets |
|---|---|
Sun Pharmaceutical Industries Ltd. | 11.49% |
Dr. Reddy's Laboratories Ltd. | 9.73% |
Cipla Ltd. | 5.79% |
Biocon Ltd. | 5.33% |
Mankind Pharma Ltd. | 5.04% |
Alkem Laboratories Ltd. | 4.81% |
Medplus Health Services Ltd. | 4.31% |
Cohance Lifesciences Ltd. | 4.06% |
Divi's Laboratories Ltd. | 3.78% |
Syngene International Ltd. | 3.50% |
Name | Assets |
|---|---|
Sun Pharmaceutical Industries Ltd. | 7.62% |
Divi's Laboratories Ltd. | 6.15% |
Dr. Reddy's Laboratories Ltd. | 5.24% |
Ajanta Pharma Ltd. | 4.81% |
Gland Pharma Ltd. | 4.06% |
Alkem Laboratories Ltd. | 3.70% |
Apollo Hospitals Enterprise Ltd. | 3.03% |
Caplin Point Laboratories Ltd. | 3.02% |
Global Health Ltd. | 2.96% |
Lupin Ltd. | 2.89% |
Name
-
-
Start Date
-
-
Description
The scheme seeks to generate long-term capital appreciation by creating a portfolio that is invested in equity and equity related securities of pharma, healthcare, hospitals, diagnostics, wellness and allied companies.
The scheme seeks to generate long term capital appreciation by investing predominantly in equity and equity related securities of companies/institutions engaged in the Healthcare Services Sector.
Launch Date
25 Jun 2018
01 Aug 2005
